Citations

Clear

17 citation(s) found for "Su, Weihua".

TMET-54. Rewiring of cortical glucose metabolism fuels human brain cancer growth
O’Brien, Alexandra, Bailleul, Justine , Zhou, Weihua , Xu, Jie , Lin, Angelica , Wilder-Romans, Kari , Korimerla, Navyateja , Feng, Jiane, Zhang, Li , Andren, Anthony , Tarnal, Vijay , Redic, Kimberly, Qi, Nathan , Fischer, J, Suresh, Krithika , Venneti, Sriram , Vlashi, Erina , Wahl, Daniel , Scott, Andrew J. , Mittal, Anjali , Meghdadi, Baharan , Palavalasa, Sravya , Achreja, Abhinav , Liang, Ningning , Kothari, Ayesha U. , Edwards, Donna , Wu, Zhe , Sajjakulnukit, Peter , Park, Junyoung O. , Hoeve, Johanna ten , Fischer, Joshua, Yang, Ethan , Regan, Michael S. , Stopka, Sylwia A. , Baquer, Gerard , Sarkaria, Jann N. , Lawrence, Theodore S. , Agar, Nathalie Y.R. , Lyssiotis, Costas A. , Al‐Holou, Wajd N. , Nagrath, Deepak

Mayo Clinic

Neuro-Oncology | November 11, 2025 | Volume: 27 | Issue: Supplement_5 | Pages: v440-v441

10.1093/neuonc/noaf201.1745 Get It

Abstract The brain avidly consumes glucose to fuel neurophysiology. Cancers of the brain, such as glioblastoma (GBM), relinquish physiological integrity and gain the ability to proliferate and invade healthy tissue. How brain cancers rewire glucose utilization to drive aggressive growth remains elusive. Here, we infused 13C-labeled glucose into patients and mice with brain cancer, coupled with quantitative metabolic flux analysis, to map the fates of glucose-derived carbon in tumor vs. cortex. Through the first direct and comprehensive measurements of carbon and nitrogen labeling in both cortex and glioma tissues, we uncover profound metabolic transformations. In human cortex, glucose carbons fuel essential physiologic processes including TCA cycle oxidation and neurotransmitter synthesis. Conversely, gliomas downregulate these processes and scavenge alternative carbon sources such as amino acids from the environment, repurposing glucose-derived carbons to generate molecules needed for proliferation and invasion. Targeting this metabolic rewiring in mice through dietary amino acid modulation selectively alters GBM metabolism, slows tumor growth, and augments the efficacy of standard-of-care treatments. These findings illuminate how aggressive brain tumors exploit glucose to suppress normal physiological activity in favor of malignant expansion and offer potential therapeutic strategies to enhance treatment outcomes.
Salivary microbiota and clinical periodontal measures predicting cardiometabolic disease mortality: A nationwide survey
Adam, Hamdi S , Guan, Weihua , Johnson, Abigail J. , Sedaghat, Sanaz , Goh, Charlene Enhui , Pankow, James S. , Goh, Charlene E , Demmer, Ryan T , Pankow, James S , Demmer, Ryan T.

Mayo Clinic

Journal of Periodontology | October 10, 2025 | Volume: 97 | Issue: 3 | Pages: 552-568

10.1002/jper.11395 | PMID 41071188 Get It

Abstract Background Although periodontitis and oral microbiota are linked to cardiometabolic diseases (CMD), it is unclear if they similarly predict CMD mortality. We compared the predictive ability of salivary microbiota and periodontal disease measures for CMD mortality in the National Health and Nutrition Examination Survey (NHANES). Methods We included 5,037 adults aged ≥30 years (mean age [± standard deviation (SD)]: 48[± 14]; 50% male) from the 2009–2010 and 2011–2012 NHANES cycles. We used 16S rRNA sequencing data from saliva to operationalize microbial composition and diversity. We calculated the relative abundance log‐ratio of Treponema (linked with periodontal disease) to Corynebacterium (linked with periodontal health) to compute the Microbial Indicator of Periodontitis (MIP). Interproximal periodontal probing depth and clinical attachment loss were measured from periodontal examinations. Mortality was ascertained through 2019. Survey‐weighted Cox models regressed mortality rates on MIP, microbial diversity, and periodontal measures to estimate hazard ratios and 95% confidence intervals (HR [95% CI]). Results Over 8.8 median follow‐up years, there were 81 CMD and 267 all‐cause deaths. After multivariable adjustment, MIP was associated with increased CMD mortality risk (HR per 1‐SD: 2.10 [1.30–3.38]). Neither microbial diversity nor periodontitis measures were associated with CMD mortality. MIP was associated with periodontitis in multivariable modeling (risk ratio per 1‐SD: 1.29 [1.22–1.39]). Conclusions In a nationally representative cohort, greater baseline salivary Treponema to Corynebacterium ratio predicted increased CMD mortality risk, while microbial diversity metrics and periodontal parameters were not significantly associated with CMD mortality. Longitudinal studies that further contextualize the oral microbiota are warranted. Plain Language Summary Bacteria in the mouth that cause gum disease are linked to cardiometabolic diseases (e.g., diabetes, cardiovascular disease, kidney disease). However, it is not well understood if bacteria of the mouth can predict the risk of death due to cardiometabolic diseases. We used data from a nationwide survey of US adults to explore whether bacteria from saliva, collected from a single time point, are associated with the future risk of cardiometabolic disease death. We found that people with higher levels of gum disease bacteria were more likely to die from cardiometabolic diseases. Future studies are needed to better understand the role of gum disease bacteria in the development of cardiometabolic diseases and the risk of death.
Deep-Learning-Based Ultrasound Computed Tomography for Material Characterization
Anwar, Shoaib, Yunker, Austin , Aktharuzzaman, Md , Kettimuthu, Rajkumar , Su, Weihua

Mayo Clinic

ASME 2025 Aerospace Structures, Structural Dynamics, and Materials Conference | June 11, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1115/ssdm2025-152112 Get It

Abstract Full waveform inversion (FWI) is one of the advanced inversion-based ultrasound computed tomography (USCT) techniques that can identify the material properties and produce high-resolution inverted images of the specimen, making it promising for applications in nondestructive evaluation (NDE) and structural health monitoring (SHM). However, this process is computationally expensive and time-consuming due to its ill-posed nature and inherent nonlinearity. To mitigate these challenges and enhance the efficiency of FWI, this study explores an alternative approach using artificial intelligence (AI) as a data-driven regularization. However, one of the major challenges in such a data-driven approach is the inadequate amount of data to train the neural network. To address this bottleneck, 2D numerically generated samples are used to train the neural network in this study. In addition, two different source time functions (STF) were used for FWI simulations to understand the effect of using different waveforms on the deep-learning (DL) based solution. The first STF was numerically generated and the second was acquired by inverting experimental data using a multi-channel data acquisition system from the Verasonics. For evaluation, the structural similarity index measure (SSIM) and peak-signal noise ratio (PSNR) metrics are used to compare the predicted images with the ground truth images. The results demonstrate the efficacy of the DL-based approach, with improvements of 22.5% and 78% in SSIM and 47% and 73% in PSNR over the classical FWI simulations for the first and second STFs, respectively. The DL-based adjoint tomography architecture for USCT presented in this work has a strong potential for material characterization and detecting internal defects and variations.
DiSC: a statistical tool for fast differential expression analysis of individual-level single-cell RNA-seq data
Zhang, L. , Yang, Lu , Ren, Yingxue , Zhang, Shuwen , Guan, Weihua, Chen, Jun , Guan, Weihua , Zhang, Lujun , Chen, Jun , Zhang, Shuwen

Mayo Clinic

Bioinformatics | May 30, 2025 | Volume: 41 | Issue: 6 | Pages: No page available

10.1093/bioinformatics/btaf327 | PMID 40444783 Get It

Abstract Motivation Single-cell RNA sequencing (scRNA-seq) has become an important method for characterizing cellular heterogeneity, revealing more biological insights than the bulk RNA-seq. The surge in scRNA-seq data across multiple individuals calls for efficient and statistically powerful methods for differential expression (DE) analysis that addresses individual-level biological variability. Results We introduced DiSC, a method for conducting individual-level DE analysis by extracting multiple distributional characteristics, jointly testing their association with a variable of interest, and using a flexible permutation testing framework to control the false discovery rate (FDR). Our simulation studies demonstrated that DiSC effectively controlled the FDR across various settings and exhibited high statistical power in detecting different types of gene expression changes. Moreover, DiSC is computationally efficient and scalable to the rapidly increasing sample sizes in scRNA-seq studies. When applying DiSC to identify DE genes potentially associated with COVID-19 severity and Alzheimer’s disease across various types of peripheral blood mononuclear cells and neural cells, we found that our method was approximately 100 times faster than other state-of-the-art methods and the results were consistent and supported by existing literature. While DiSC was developed for scRNA-seq data, its robust testing framework can also be applied to other types of single-cell data. We applied DiSC to cytometry by time-of-flight data, DiSC identified significantly more DE markers than traditional methods. Availability and implementation The R software package “SingleCellStat” is freely available on CRAN (https://cran.r-project.org/web/packages/SingleCellStat/index.html) and GitHub (https://github.com/Lujun995/DiSC). The replication code for reproducing the analyses in this study is publicly accessible at https://github.com/Lujun995/DiSC_Replication_Code. The scRNA-seq expression matrix and metadata utilized in our simulations and analyses can be retrieved from https://cells.ucsc.edu/autism/rawMatrix.zip, https://cellxgene.cziscience.com/collections/1ca90a2d-2943-483d-b678-b809bf464c30, and https://covid19.cog.sanger.ac.uk/submissions/release1/haniffa21.processed.h5ad.
Federated Learning for Renal Tumor Segmentation and Classification on Multi‐Center MRI Dataset
Nguyen, Dat‐Thanh , Imami, Maliha , Zhao, Linmei , Wu, Jing , Borhani, Ali , Khunte, Mihir , Zhong, Zhusi , Shi, Victoria, Yao, Sophie, Wang, Yuli , Loizou, Nicolas , Silva, Alvin C. , Zhang, Paul J. , Zhang, Zishu , Kamel, Ihab R. , Liao, Weihua , Bai, Harrison X. , Bai, Harrison X. , Kamel, Ihab R , Mohseni, Alireza , Yao, Sophie, Jiao, Zhicheng

Mayo Clinic

Journal of Magnetic Resonance Imaging | May 19, 2025 | Volume: 62 | Issue: 3 | Pages: 814-824

10.1002/jmri.29819 | PMID 40384349 Get It

ABSTRACTBackgroundDeep learning (DL) models for accurate renal tumor characterization may benefit from multi‐center datasets for improved generalizability; however, data‐sharing constraints necessitate privacy‐preserving solutions like federated learning (FL).PurposeTo assess the performance and reliability of FL for renal tumor segmentation and classification in multi‐institutional MRI datasets.Study TypeRetrospective multi‐center study.PopulationA total of 987 patients (403 female) from six hospitals were included for analysis. 73% (723/987) had malignant renal tumors, primarily clear cell carcinoma (n = 509). Patients were split into training (n = 785), validation (n = 104), and test (n = 99) sets, stratified across three simulated institutions.Field Strength/SequenceMRI was performed at 1.5 T and 3 T using T2‐weighted imaging (T2WI) and contrast‐enhanced T1‐weighted imaging (CE‐T1WI) sequences.AssessmentFL and non‐FL approaches used nnU‐Net for tumor segmentation and ResNet for its classification. FL‐trained models across three simulated institutional clients with central weight aggregation, while the non‐FL approach used centralized training on the full dataset.Statistical TestsSegmentation was evaluated using Dice coefficients, and classification between malignant and benign lesions was assessed using accuracy, sensitivity, specificity, and area under the curves (AUCs). FL and non‐FL performance was compared using the Wilcoxon test for segmentation Dice and Delong's test for AUC (p < 0.05).ResultsNo significant difference was observed between FL and non‐FL models in segmentation (Dice: 0.43 vs. 0.45, p = 0.202) or classification (AUC: 0.69 vs. 0.64, p = 0.959) on the test set. For classification, no significant difference was observed between the models in accuracy (p = 0.912), sensitivity (p = 0.862), or specificity (p = 0.847) on the test set.Data ConclusionFL demonstrated comparable performance to non‐FL approaches in renal tumor segmentation and classification, supporting its potential as a privacy‐preserving alternative for multi‐institutional DL models.Evidence Level4.Technical EfficacyStage 2.
Abstract A004: GTP signaling links metabolism, DNA repair, and responses to genotoxic stress
Zhou, Weihua , Zhao, Zitong , Lin, Angelica , Xu, Jie , Wilder-Romans, Kari , Yang, Annabel , Solanki, Sumeet , Yao, Yangyang , Peterson, Erik , Korimerla, Navyateja , Werner, Christian K. , Liang, Jessica , Jacobson, Janna , O'Brien, Alexandra, Elaimy, Ameer L. , Ferris, Sean P. , Zhao, Shuang G. , Zhang, Shuqun , Morgan, Meredith A. , Lawrence, Theodore S. , Lyssiotis, Costas A. , Peters‐Golden, Marc , Wahl, Daniel , Lawrence, Theodore S , Lyssiotis, Costas A , Yang, John, Scott, Andrew J. , Li, Jing , Speth, Jennifer M. , Walker, Natalie , Kothari, Ayesha U. , Palavalasa, Sravya , Zhao, Shuang G , Sarkaria, Jann N. , Győrffy, Balázs , Al‐Holou, Wajd N. , Umemura, Yoshie , Shah, Yatrik M

Mayo Clinic

Cancer Research | March 4, 2024 | Volume: 84 | Issue: 5_Supplement_1 | Pages: A004-A004

10.1158/1538-7445.brain23-a004 Get It

Abstract OBJECTIVE: We sought to define the mechanisms by which purines regulate DNA repair and therapy response. METHODS: Phosphoproteomics was used to identify GTP-dependent (de)phosphorylation events after radiation (RT) and antibodies generated against novel sites. Animal models of glioblastoma (GBM) and normal tissues were used to assess DNA repair and treatment responses in vivo. RESULTS: Pharmacogenomic inhibition of GTP (but not ATP) synthesis sensitized GBM cells to RT by inhibiting the activity of non-homologous end joining, but not homologous recombination. We found a GTP-dependent RT-induced dephosphorylation event on Abl interactor 1 (Abi-1) serine 323 (S323) using phosphoproteomics. We generated a new antibody for p-Abi-1 (S323), validated its specificity, and confirmed that RT causes a GTP-dependent dephosphorylation of Abi-1 (S323). Knockout of Abi-1 slowed RT-induced double-strand break (DSB) repair, and this was rescued by re-expression of dephosphomimetic Abi-1 (S323A) but not phosphomimetic Abi-1 (S323D). Abi-1 canonically binds to G protein Rac1. Expression of constitutively active Rac1 promoted but dominant negative Rac1 blocked the dephosphorylation of Abi-1 (S323) and DSB repair. Knock-down or inhibition of protein phosphatase 5 reversed the GTP- and Rac1-mediated dephosphorylation of Abi-1 and DSB repair. In GBM PDX samples, p-Abi-1 (S323) levels negatively correlated with Rac1 activity and predicted favorable efficacy of genotoxic treatments. In orthotopic GBM mouse models, inhibiting Rac1 enhanced RT responses and suppressed Abi-1 (S323) dephosphorylation. Abi-1 knockout enhanced efficacy of genotoxic treatments and could be rescued by Abi-1 S323A (but not Abi-1 S323D) re-expression. This regulation is generalizable beyond brain cancer, as GTP supplementation promoted DNA repair and p-Abi1 (S323) dephosphorylation in non-malignant cells and protected mice from RT-mediated gastrointestinal injury and bleomycin-induced pulmonary fibrosis. CONCLUSION: The GTP-Rac1-PP5-Abi-1 signaling axis links metabolism and DNA repair. Disrupting this pathway can overcome cancer resistance to genotoxic therapy while augmenting it can mitigate genotoxic injury of normal tissues. Citation Format: Weihua Zhou, Zitong Zhao, Angelica Lin, John Yang, Jie Xu, Kari Wilder-Romans, Annabel Yang, Andrew J. Scott, Jing Li, Sumeet Solanki, Jennifer Speth, Natalie Walker, Ayesha U. Kothari, Yangyang Yao, Erik R. Peterson, Navyateja Korimerla, Christian K. Werner, Jessica Liang, Janna Jacobson, Sravya Palavalasa, Alexandra M Obrien, Ameer L Elaimy, Sean P. Ferris, Shuang G. Zhao, Jann N. Sarkaria, Balázs Győrffy, Shuqun Zhang, Wajd N. Al-Holou, Yoshie Umemura, Meredith A Morgan, Theodore S. Lawrence, Costas A. Lyssiotis, Marc Peters-Golden, Yatrik M. Shah, Daniel R. Wahl. GTP signaling links metabolism, DNA repair, and responses to genotoxic stress [abstract]. In: Proceedings of the AACR Special Conference on Brain Cancer; 2023 Oct 19-22; Minneapolis, Minnesota. Philadelphia (PA): AACR; Cancer Res 2024;84(5 Suppl_1):Abstract nr A004.
RBIO-08. GTP SIGNALING LINKS ALTERED METABOLISM, DNA REPAIR AND TREATMENT RESISTANCE IN GLIOBLASTOMA
Zhou, Weihua , Zhao, Zitong , Lin, Angelica , Xu, Jie , Wilder-Romans, Kari , Yang, Annabel , Solanki, Sumeet , Yao, Yangyang , Korimerla, Navyateja , Werner, Christian K. , Liang, Jessica , Jacobson, Janna , O’Brien, Alexandra M., Elaimy, Ameer L. , Ferris, Sean P. , Zhao, Shuang G. , Al-Holou, Wajd, Morgan, Meredith A. , Lyssiotis, Costas A. , Peters‐Golden, Marc , Wahl, Daniel , Al‐Holou, Wajd N. , Lyssiotis, Costas A , Al-Holou, Wajd N , Yang, John, Li, Jing , Speth, Jennifer M. , Walker, Natalie , Scott, Andrew J. , Kothari, Ayesha U. , Peterson, Erik, Palavalasa, Sravya , Zhao, Shuang G , Sarkaria, Jann N. , Győrffy, Balázs , Zhang, Shuqun , Umemura, Yoshie , Lawrence, Theodore S. , Shah, Yatrik M

Mayo Clinic

Neuro-Oncology | November 11, 2023 | Volume: 25 | Issue: Supplement_5 | Pages: v257-v257

10.1093/neuonc/noad179.0988 Get It

Abstract OBJECTIVE We sought to define the mechanisms by which purines regulate DNA repair and therapy response. METHODS Phosphoproteomics was used to identify GTP-dependent (de)phosphorylation events after radiation (RT) and antibodies generated against novel sites. Animal models of glioblastoma (GBM) and normal tissues were used to assess DNA repair and treatment responses in vivo. RESULTS Pharmacogenomic inhibition of GTP (but not ATP) synthesis sensitized GBM cells to RT by inhibiting the activity of non-homologous end joining, but not homologous recombination. We found a GTP-dependent RT-induced dephosphorylation event on Abl interactor 1 (Abi-1) serine 323 (S323) using phosphoproteomics. We generated a new antibody for p-Abi-1 (S323), validated its specificity, and confirmed that RT causes a GTP-dependent dephosphorylation of Abi-1 (S323). Knockout of Abi-1 slowed RT-induced double-strand break (DSB) repair, and this was rescued by re-expression of dephosphomimetic Abi-1 (S323A) but not phosphomimetic Abi-1 (S323D). Abi-1 canonically binds to G protein Rac1. Expression of constitutively active Rac1 promoted but dominant negative Rac1 blocked the dephosphorylation of Abi-1 (S323) and DSB repair. Knock-down or inhibition of protein phosphatase 5 reversed the GTP- and Rac1-mediated dephosphorylation of Abi-1 and DSB repair. In GBM PDX samples, p-Abi-1 (S323) levels negatively correlated with Rac1 activity and predicted favorable efficacy of genotoxic treatments. In orthotopic GBM mouse models, inhibiting Rac1 enhanced RT responses and suppressed Abi-1 (S323) dephosphorylation. Abi-1 knockout enhanced efficacy of genotoxic treatments and could be rescued by Abi-1 S323A (but not Abi-1 S323D) re-expression. This regulation is generalizable beyond brain cancer, as GTP supplementation promoted DNA repair and p-Abi1 (S323) dephosphorylation in non-malignant cells and protected mice from RT-mediated gastrointestinal injury and bleomycin-induced pulmonary fibrosis. CONCLUSION The GTP-Rac1-PP5-Abi-1 signaling axis links metabolism and DNA repair. Disrupting this pathway can overcome GBM resistance to genotoxic therapy while augmenting it can mitigate genotoxic injury of normal tissues.
GTP Signaling Links Metabolism, DNA Repair, and Responses to Genotoxic Stress
Zhou, Weihua , Zhao, Zitong , Lin, Angelica , Yang, John Z. , Xu, Jie , Wilder-Romans, Kari , Yang, Annabel , Li, Jing , Solanki, Sumeet , Speth, Jennifer M. , Scott, Andrew J. , Wang, L. , Wen, Bo , Andren, Anthony , Zhang, Li , Yao, Yangyang , Peterson, Erik , Korimerla, Navyateja , Werner, Christian K. , Ullrich, Alexander , Liang, Jessica , Jacobson, Janna , O’Brien, Alexandra M., Elaimy, Ameer L. , Ferris, Sean P. , Zhao, Shuang G. , Zhang, Shuqun , Al‐Holou, Wajd N. , Umemura, Yoshie , Morgan, Meredith A. , Lawrence, Theodore S. , Lyssiotis, Costas A. , Peters‐Golden, Marc , Wahl, Daniel , Walker, Natalie , Scott, Andrew J , Wang, Lu , Wen, Bo , Andren, Anthony , Zhang, Li , Kothari, Ayesha U , Yao, Yangyang , Peterson, Erik , Korimerla, Navyateja , Werner, Christian K , Ullrich, Alexander , Liang, Jessica , Jacobson, Janna , Palavalasa, Sravya , O'Brien, Alexandra M , Elaimy, Ameer L , Ferris, Sean P , Zhao, Shuang G , Sarkaria, Jann N , Győrffy, Balázs , Zhang, Shuqun , Al-Holou, Wajd N , Umemura, Yoshie , Morgan, Meredith A , Lawrence, Theodore S , Lyssiotis, Costas A , Peters-Golden, Marc , Shah, Yatrik M , Wahl, Daniel , Kothari, Ayesha U. , Sarkaria, Jann N. , Győrffy, Balázs

Mayo Clinic

Cancer Discovery | October 30, 2023 | Volume: 14 | Issue: 1 | Pages: 158-175

10.1158/2159-8290.cd-23-0437 | PMID 37902550 Get It

ABSTRACT How cell metabolism regulates DNA repair is incompletely understood. Here, we define a GTP-mediated signaling cascade that links metabolism to DNA repair and has significant therapeutic implications. GTP, but not other nucleotides, regulates the activity of Rac1, a guanine nucleotide-binding protein, which promotes the dephosphorylation of serine 323 on Abl-interactor 1 (Abi-1) by protein phosphatase 5 (PP5). Dephosphorylated Abi-1, a protein previously not known to activate DNA repair, promotes nonhomologous end joining. In patients and mouse models of glioblastoma, Rac1 and dephosphorylated Abi-1 mediate DNA repair and resistance to standard-of-care genotoxic treatments. The GTP–Rac1–PP5–Abi-1 signaling axis is not limited to brain cancer, as GTP supplementation promotes DNA repair and Abi-1-S323 dephosphorylation in nonmalignant cells and protects mouse tissues from genotoxic insult. This unexpected ability of GTP to regulate DNA repair independently of deoxynucleotide pools has important implications for normal physiology and cancer treatment. SIGNIFICANCE: A newly described GTP-dependent signaling axis is an unexpected link between nucleotide metabolism and DNA repair. Disrupting this pathway can overcome cancer resistance to genotoxic therapy while augmenting it can mitigate genotoxic injury of normal tissues. This article is featured in Selected Articles from This Issue, p. 5
Abstract 3498: GTP-dependent signaling links metabolism, non-homologous end joining and treatment responses in cancer and normal tissues
Zhou, Weihua , Lin, Angelica , Zhao, Zitong , Wilder-Romans, Kari , Xu, Jie , Solanki, Sumeet , Yang, Annabel , Korimerla, Navyateja , Liang, Jessica , Jacobson, Janna , O’Brien, Alexandra M., Ferris, Sean P. , Zhao, Shuang G. , Morgan, Meredith A. , Lawrence, Theodore S. , Lyssiotis, Costas A. , Shah, Yatrik M., Wahl, Daniel , Lawrence, Theodore S , Lyssiotis, Costas A , Yang, John, Li, Jing , Scott, Andrew J. , Kothari, Ayesha U. , Peterson, Erik, Palavalasa, Sravya , Zhao, Shuang G , Sarkaria, Jann N. , Shah, Yatrik M

Mayo Clinic

Cancer Research | April 5, 2023 | Volume: 83 | Issue: 7_Supplement | Pages: 3498-3498

10.1158/1538-7445.am2023-3498 Get It

Abstract Introduction/Objectives: Purines regulate DNA repair in brain tumors through uncertain mechanisms. We sought to define the mechanisms by which purines regulate DNA repair and therapy response. Methods: Crispr/Cas9, siRNA, and CDNA overexpression and immunoblot were used to modulate and confirm protein levels. γ-H2AX and Rad51 foci were enumerated using immunofluorescence. Fluorescent reporter assays were performed to detect DNA repair activity. Phosphoproteomics was used to identify GTP-dependent (de)phosphorylation events after RT and antibodies generated against novel sites. Celltiter-glo or clonogenic assay were performed to evaluate drug/RT responses. IHC was used to detect protein expression. Animal models of glioblastoma and normal tissue (irradiation of GI system) were used to assess DNA repair and treatment responses in vivo. Results: Pharmacogenomic inhibition of GTP (but not ATP) synthesis sensitized GBM cells to RT, slowed the repair of RT-induced DSBs and inhibited the activity of non-homologous end joining (NHEJ), but not homologous recombination (HR). These effects could be rescued by GTP (but not ATP) supplementation. We found a GTP-dependent RT-induced dephosphorylation event on Abl interactor 1 (Abi-1) serine 323 (S323) using phosphoproteomics. We generated a new antibody for p-Abi-1 (S323), validated its specificity, and confirmed that RT causes a GTP-dependent dephosphorylation of Abi-1 (S323). Knockout of Abi-1 slowed RT-induced DSB repair and this was rescued by re-expression of dephosphomimetic Abi-1 (S323A) but not phosphomimetic Abi-1 (S323D). Abi-1 canonically binds to the small GTP-activated protein Rac1. Expression of constitutively active Rac1 promoted the dephosphorylation of Abi-1 (S323) and DSB repair while these effects were blocked by dominant negative Rac1. Pharmacogenomic inhibition of protein phosphatase 5 reversed the GTP- and Rac1-mediated dephosphorylation of Abi-1 and DSB repair. These findings have therapeutic relevance. In GBM PDX samples, levels of p-Abi-1 (S323) negatively correlated with Rac1 activity and predicted favorable efficacy of genotoxic treatments. In orthotopic GBM mouse models, inhibition of Rac1 enhanced RT responses and suppressed Abi-1 S323 dephosphorylation. Abi-1 knockout enhanced efficacy of numerous genotoxic treatments and could be rescued by Abi-1 S323A (but not Abi-1 S323D) re-expression. This regulation is generalizable beyond brain cancer, as GTP supplementation promoted DNA repair and p-Abi1 (S323) dephosphorylation in normal astrocytes and enteroids and protected mice from RT-mediated gastrointestinal injury. Conclusions: GTP promotes DNA repair by activating Rac1 and PP5 to dephosphorylate Abi-1 and stimulate NHEJ. Disrupting this regulation could improve brain tumor treatment responses while augmenting it could help protect normal tissues from genotoxic injury. Citation Format: Weihua Zhou, Angelica Lin, Zitong Zhao, John Yang, Kari Wilder-Romans, Jie Xu, Sumeet Solanki, Jing Li, Annabel Yang, Andrew Scott, Ayesha Kothari, Erik Peterson, Navyateja Korimerla, Jessica Liang, Janna Jacobson, Sravya Palavalasa, Alexandra Obrien, Sean Ferris, Shuang Zhao, Jann N. Sarkaria, Meredith Morgan, Theodore S. Lawrence, Costas A. Lyssiotis, Yatrik Shah, Daniel R. Wahl. GTP-dependent signaling links metabolism, non-homologous end joining and treatment responses in cancer and normal tissues [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 3498.
Cyclin D2 Overexpression Enhances the Efficacy of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes for Myocardial Repair in a Swine Model of Myocardial Infarction
Zhao, Meng , Nakada, Yuji , Wei, Yuhua , Bian, Weihua , Chu, Yuxin , Borovjagin, Anton V. , Xie, Min , Zhu, Wuqiang , Nguyen, Thanh , Zhou, Yang , Walcott, Gregory P. , Zhang, Jianyi , Zhu, Wuqiang , Serpooshan, Vahid

Mayo Clinic

Circulation | May 6, 2021 | Volume: 144 | Issue: 3 | Pages: 210-228

10.1161/circulationaha.120.049497 | PMID 33951921 Get It

Background: Human induced pluripotent stem cells with normal (wild-type) or upregulated (overexpressed) levels of CCND2 (cyclin D2) expression were differentiated into cardiomyocytes (CCND2 WT CMs or CCND2 OE CMs, respectively) and injected into infarcted pig hearts. Methods: Acute myocardial infarction was induced by a 60-minute occlusion of the left anterior descending coronary artery. Immediately after reperfusion, CCND2 WT CMs or CCND2 OE CMs (3×10 7 cells each) or an equivalent volume of the delivery vehicle was injected around the infarct border zone area. Results: The number of the engrafted CCND2 OE CMs exceeded that of the engrafted CCND2 WT CMs from 6- to 8-fold, rising from 1 week to 4 weeks after implantation. In contrast to the treatment with the CCND2 WT CMs or the delivery vehicle, the administration of CCND2 OE CM was associated with significantly improved left ventricular function, as revealed by magnetic resonance imaging. This correlated with reduction of infarct size, fibrosis, ventricular hypertrophy, and cardiomyocyte apoptosis, and increase of vascular density and arterial density, as per histologic analysis of the treated hearts. Expression of cell proliferation markers (eg, Ki67, phosphorylated histone 3, and Aurora B kinase) was also significantly upregulated in the recipient cardiomyocytes from the CCND2 OE CM-treated than from the CCND2 WT CM-treated pigs. The cell proliferation rate and the hypoxia tolerance measured in cultured human induced pluripotent stem cell cardiomyocytes were significantly greater after treatment with exosomes isolated from the CCND2 OE CMs (CCND2 OE Exos) than from the CCND2 WT CMs (CCND2 WT Exos). As demonstrated by our study, CCND2 OE Exos can also promote the proliferation activity of postnatal rat and adult mouse cardiomyocytes. A bulk miRNA sequencing analysis of CCND2 OE Exos versus CCND2 WT Exos identified 206 and 91 miRNAs that were significantly upregulated and downregulated, respectively. Gene ontology enrichment analysis identified significant differences in the expression profiles of miRNAs from various functional categories and pathways, including miRNAs implicated in cell-cycle checkpoints (G2/M and G1/S transitions), or the mechanism of cytokinesis. Conclusions: We demonstrated that enhanced potency of CCND2 OE CMs promoted myocyte proliferation in both grafts and recipient tissue in a large mammal acute myocardial infarction model. These results suggest that CCND2 OE CMs transplantation may be a potential therapeutic strategy for the repair of infarcted hearts.